Application of the Lancet Commission Copd Classification to Copd Cohort Population

25 Pages Posted: 29 Feb 2024

See all articles by Hyonsoo Joo

Hyonsoo Joo

Catholic University of Korea

Hyoung Kyu Yoon

Catholic University of Korea

Yong Il Hwang

Hallym University - Hallym University Sacred Heart Hospital

Sang Hyuk Kim

Dongguk University

Soo-Jung Um

Dong-A University

Won-Yeon Lee

Yonsei University

Ki-Suck Jung

Hallym University - Hallym University Sacred Heart Hospital

Kwang Ha Yoo

Konkuk University - Konkuk University Medical Center

Woo Jin Kim

Kangwon National University

Chin Kook Rhee

Catholic University of Korea

Abstract

Objectives The Lancet Commissions on COPD recommended a new classification based on five main risk factors. To apply the proposed typing to a real-world patient cohort, evaluate the distribution of patients across each type, determine the extent of overlap, and compare and analyze the characteristics of non-overlapping patients.

Methods Patients with COPD were prospectively enrolled in a Korean COPD subgroup study cohort between April 2012 and June 2022. Patients were asked questions were about their history and classified based on their answers.

Results The database enrolled 3477 patients, including 52, 1293, 2931, and 2221 patients with type 2, 3, 4, and 5, respectively. Most patients (69.2%, 2406) had multiple risk factors contributing to their COPD. However, 93, 712, and 182 patients had only type 3, 4, and 5, respectively. Type 3 only patients were significantly younger, more often female, and had lower lung function. Both the rate and frequency of severe exacerbations were significantly higher in type 3 only patients (p=0.038 and p=0.048, respectively). Compared with type 5 only, type 3 only was significantly associated with the risk of severe exacerbation (Odds ratio, 5.713 [95% CI, 1.007-32.403]; P=0.049, incident rate ratio, 8.689 [95% CI, 1.7147 - 43.972]; P=0.009).

Conclusions Many patients were affected by multiple factors. Therefore, it is important to consider not only smoking history, but also other potential risk factors when evaluating patients with COPD. Further research is needed to explore the implications of this new COPD classification system for clinical practice and treatment strategies.

Note:
Funding Declaration: None.

Conflicts of Interest: None.

Ethical Approval: All hospitals involved in the study obtained approval from their respective institutional review board committees, and informed consent was obtained from all patients. The present study complied with the Declaration of Helsinki and all methods were performed in accordance with the relevant guidelines.

Keywords: Chronic obstructive pulmonary disease, Classification, exacerbation

Suggested Citation

Joo, Hyonsoo and Yoon, Hyoung Kyu and Hwang, Yong Il and Kim, Sang Hyuk and Um, Soo-Jung and Lee, Won-Yeon and Jung, Ki-Suck and Yoo, Kwang Ha and Kim, Woo Jin and Rhee, Chin Kook, Application of the Lancet Commission Copd Classification to Copd Cohort Population. Available at SSRN: https://ssrn.com/abstract=4728158 or http://dx.doi.org/10.2139/ssrn.4728158

Hyonsoo Joo (Contact Author)

Catholic University of Korea ( email )

Hyoung Kyu Yoon

Catholic University of Korea ( email )

Yong Il Hwang

Hallym University - Hallym University Sacred Heart Hospital ( email )

Anyang
Korea, Republic of (South Korea)

Sang Hyuk Kim

Dongguk University ( email )

Soo-Jung Um

Dong-A University ( email )

Won-Yeon Lee

Yonsei University ( email )

Ki-Suck Jung

Hallym University - Hallym University Sacred Heart Hospital ( email )

Anyang
Korea, Republic of (South Korea)

Kwang Ha Yoo

Konkuk University - Konkuk University Medical Center ( email )

120 Neungdong-ro, Gwangjin-gu
Seoul 143-701, Korea
Korea, Republic of (South Korea)

Woo Jin Kim

Kangwon National University ( email )

Chin Kook Rhee

Catholic University of Korea ( email )

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
30
Abstract Views
203
PlumX Metrics